1. First evidence for N7-Platinated Guanosine derivatives cell uptake mediated by plasma membrane transport processes
- Author
-
Tiziano Verri, Francesco Paolo Fanizzi, Alessandro Romano, Danilo Migoni, Amilcare Barca, Erik De Luca, Michele Benedetti, Chiara Roberta Girelli, Federica De Castro, De Castro, F., De Luca, E., Girelli, C. R., Barca, A., Romano, A., Migoni, D., Verri, T., Benedetti, M., and Fanizzi, F. P.
- Subjects
Organoplatinum Compounds ,Stereochemistry ,Cell ,Guanosine ,Antitumor drug ,HeLa Cell ,Biochemistry ,Metalated purine ,Inorganic Chemistry ,HeLa ,chemistry.chemical_compound ,medicine ,Humans ,Cytotoxicity ,biology ,Chemistry ,Cytotoxins ,Cell Membrane ,Antiviral drug ,Biological Transport ,Metabolism ,Membrane transport ,Nucleoside analogue ,biology.organism_classification ,medicine.anatomical_structure ,Membrane ,Nucleic acid ,Cytotoxin ,Platinum based drug ,HeLa Cells ,Human - Abstract
Nucleos(t)ide analogues (NA) belong to a family of compounds widely used in anticancer/antiviral treatments. They generally exhibit a cell toxicity limited by cellular uptake levels and the resulting nucleos(t)ides metabolism modifications, interfering with the cell machinery for nucleic acids synthesis. We previously synthesized purine nucleos(t)ide analogues N7-coordinated to a platinum centre with unaltered sugar moieties of the type: [Pt(dien)(N7-dGuo)]2+ (1; dien = diethylenetriamine; dGuo = 2'-deoxy-guanosine), [Pt(dien)(N7-dGMP)] (2; dGMP = 5'-(2'-deoxy)-guanosine monophosphate), and [Pt(dien)(N7-dGTP)]2- (3; dGTP = 5'-(2'-deoxy)-guanosine triphosphate), where the indicated electric charge is calculated at physiological pH (7.4). In this work, we specifically investigated the uptake of these complexes (1-3) at the plasma membrane level. Specific experiments on HeLa cervical cancer cells indicated a relevant cellular uptake of the model platinated deoxynucleos(t)ide 1 and 3 while complex 2 appeared unable to cross the cell plasma membrane. Obtained data buttress an uptake mechanism involving Na+-dependent concentrative transporters localized at the plasma membrane level. Consistently, 1 and 3 showed higher cytotoxicity with respect to complex 2 also suggesting selective possible applications as antiviral/antitumor drugs among the used model compounds.
- Published
- 2022